Published in Biochem Pharmacol on August 12, 2013
Nicotinic ACh receptors as therapeutic targets in CNS disorders. Trends Pharmacol Sci (2015) 1.26
The therapeutic promise of positive allosteric modulation of nicotinic receptors. Eur J Pharmacol (2014) 0.89
α9-nicotinic acetylcholine receptors contribute to the maintenance of chronic mechanical hyperalgesia, but not thermal or mechanical allodynia. Mol Pain (2014) 0.85
Acute analgesic effects of nicotine and tobacco in humans: a meta-analysis. Pain (2016) 0.83
Artemin growth factor increases nicotinic cholinergic receptor subunit expression and activity in nociceptive sensory neurons. Mol Pain (2014) 0.82
Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management? Toxins (Basel) (2015) 0.78
Tonic nicotinic transmission enhances spinal GABAergic presynaptic release and the frequency of spontaneous network activity. Dev Neurobiol (2015) 0.78
Cholinergic mechanisms in spinal locomotion-potential target for rehabilitation approaches. Front Neural Circuits (2014) 0.78
Smoking is associated with a worse self-reported health status in patients with psoriatic arthritis: data from a Swedish population-based cohort. Clin Rheumatol (2014) 0.78
The α7 nicotinic receptor dual allosteric agonist and positive allosteric modulator GAT107 reverses nociception in mouse models of inflammatory and neuropathic pain. Br J Pharmacol (2016) 0.76
Characterization of the Antinociceptive Mechanisms of Khat Extract (Catha edulis) in Mice. Front Neurol (2017) 0.75
Plasticity in Brainstem Mechanisms of Pain Modulation by Nicotinic Acetylcholine Receptors in the Rat. eNeuro (2017) 0.75
Calcium imaging with genetically encoded sensor Case12: Facile analysis of α7/α9 nAChR mutants. PLoS One (2017) 0.75
RgIA4 Potently Blocks Mouse α9α10 nAChRs and Provides Long Lasting Protection against Oxaliplatin-Induced Cold Allodynia. Front Cell Neurosci (2017) 0.75
The interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α represents a new antinociceptive signaling pathway in mice. Exp Neurol (2017) 0.75
Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature (2002) 12.09
Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend (2005) 6.91
College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend (2003) 6.80
Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain (2008) 2.38
alpha 5 Subunit alters desensitization, pharmacology, Ca++ permeability and Ca++ modulation of human neuronal alpha 3 nicotinic receptors. J Pharmacol Exp Ther (1998) 2.33
Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nat Neurosci (2002) 2.24
Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature (1999) 2.13
Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels. Nature (1996) 2.06
Allosteric modulation of nicotinic acetylcholine receptors. Biochem Pharmacol (2007) 1.98
Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science (1998) 1.87
Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits. J Biol Chem (1996) 1.80
A randomized trial to increase smoking intervention by physicians. Doctors Helping Smokers, Round I. JAMA (1989) 1.73
Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor. J Neurosci (2001) 1.72
A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain. Pain (2009) 1.64
Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice. J Pharmacol Exp Ther (2010) 1.57
Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells. AAPS J (2006) 1.52
Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors. Proc Natl Acad Sci U S A (2006) 1.42
Dorsal root ganglion neurons express multiple nicotinic acetylcholine receptor subtypes. J Neurophysiol (2001) 1.42
Transmitters involved in antinociception in the spinal cord. Brain Res Bull (1999) 1.41
Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther (1985) 1.32
Analgesic alpha-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation. J Neurosci (2008) 1.29
The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model. Neuropharmacology (2000) 1.28
A-366833: a novel nicotinonitrile-substituted 3,6-diazabicyclo[3.2.0]-heptane alpha4beta2 nicotinic acetylcholine receptor selective agonist: Synthesis, analgesic efficacy and tolerability profile in animal models. Biochem Pharmacol (2007) 1.27
The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist. Bioorg Med Chem Lett (2001) 1.25
Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice. J Pharmacol Exp Ther (1998) 1.22
Comparison of alpha2 nicotinic acetylcholine receptor subunit mRNA expression in the central nervous system of rats and mice. J Comp Neurol (2005) 1.21
Nicotine-produced antinociception in minimally deprived smokers and ex-smokers. Addict Behav (1986) 1.13
Characterization of the human nicotinic acetylcholine receptor subunit alpha (alpha) 9 (CHRNA9) and alpha (alpha) 10 (CHRNA10) in lymphocytes. Life Sci (2004) 1.10
The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury. Pain (2004) 1.08
Coexpression of alpha 9 and alpha 10 nicotinic acetylcholine receptors in rat dorsal root ganglion neurons. Neuroscience (2002) 1.06
Short- and long-term enhancement of excitatory transmission in the spinal cord dorsal horn by nicotinic acetylcholine receptors. Proc Natl Acad Sci U S A (2003) 1.04
An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants. Biochem Pharmacol (2011) 1.02
Alkaloids from frog skin: the discovery of epibatidine and the potential for developing novel non-opioid analgesics. Nat Prod Rep (2000) 1.01
Antinociceptive effects of central and systemic administrations of nicotine in the rat. Psychopharmacology (Berl) (1979) 1.00
α4β2 neuronal nicotinic receptor positive allosteric modulation: an approach for improving the therapeutic index of α4β2 nAChR agonists in pain. Biochem Pharmacol (2011) 1.00
Characterization of neuronal nicotinic acetylcholine receptors in the membrane of unmyelinated human C-fiber axons by in vitro studies. J Neurophysiol (2003) 1.00
Efficacy and tolerability of tropisetron in primary fibromyalgia--a highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study Group. Scand J Rheumatol Suppl (2000) 0.98
Nicotinic AChR in subclassified capsaicin-sensitive and -insensitive nociceptors of the rat DRG. J Neurophysiol (2004) 0.98
Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA. J Neurochem (2012) 0.97
The α3β4* nicotinic acetylcholine receptor subtype mediates nicotine reward and physical nicotine withdrawal signs independently of the α5 subunit in the mouse. Neuropharmacology (2013) 0.97
Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism. Brain Res (2002) 0.96
Nicotine differentially activates inhibitory and excitatory neurons in the dorsal spinal cord. Pain (2004) 0.96
Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent pain. Pain (2010) 0.96
Nicotine facilitates glycine release in the rat spinal dorsal horn. J Physiol (2001) 0.95
Antinociceptive effects of choline against acute and inflammatory pain. Neuroscience (2005) 0.95
Effects of α7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models. Neuropharmacology (2012) 0.94
(+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. J Pharmacol Exp Ther (1994) 0.92
Unravelling the mechanism of action of NS9283, a positive allosteric modulator of (α4)3(β2)2 nicotinic ACh receptors. Br J Pharmacol (2013) 0.91
Tonic nicotinic modulation of serotoninergic transmission in the spinal cord. Proc Natl Acad Sci U S A (2001) 0.91
Expression of alpha-7 and alpha-4 nicotinic acetylcholine receptors by GABAergic neurons of rostral ventral medulla and caudal pons. Brain Res (2007) 0.90
Nicotinic modulation of GABAergic synaptic transmission in the spinal cord dorsal horn. Brain Res (2005) 0.90
Tonic inhibitory role of alpha4beta2 subtype of nicotinic acetylcholine receptors on nociceptive transmission in the spinal cord in mice. Pain (2006) 0.90
Knock down of the alpha 5 nicotinic acetylcholine receptor in spinal nerve-ligated rats alleviates mechanical allodynia. Pharmacol Biochem Behav (2004) 0.90
A Review of Potential Adverse Effects of Long-Term Opioid Therapy: A Practitioner's Guide. Prim Care Companion CNS Disord (2012) 0.89
The effect of peripherally administered CDP-choline in an acute inflammatory pain model: the role of alpha7 nicotinic acetylcholine receptor. Anesth Analg (2009) 0.89
Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists. Neuropharmacology (1998) 0.89
PSAB-OFP, a selective alpha 7 nicotinic receptor agonist, is also a potent agonist of the 5-HT3 receptor. Eur J Pharmacol (2002) 0.88
Neuronal nicotinic alpha7 receptors modulate inflammatory cytokine production in the skin following ultraviolet radiation. J Neuroimmunol (2008) 0.88
Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats. Biochem Pharmacol (2011) 0.88
Role of the nucleus raphe magnus in antinociception produced by ABT-594: immediate early gene responses possibly linked to neuronal nicotinic acetylcholine receptors on serotonergic neurons. J Neurosci (1998) 0.87
Opioid and nicotinic analgesic and hyperalgesic loci in the rat brain stem. J Pharmacol Exp Ther (1992) 0.87
Antinociceptive and anti-inflammatory effects of choline in a mouse model of postoperative pain. Br J Anaesth (2010) 0.87
In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model. Br J Pharmacol (2013) 0.87
Alpha 4 nicotinic acetylcholine receptor subunit links cholinergic to brainstem monoaminergic neurotransmission. Synapse (2003) 0.86
Low concentrations of amitriptyline inhibit nicotinic receptors in unmyelinated axons of human peripheral nerve. Br J Pharmacol (2009) 0.85
The antinociceptive effects of centrally administered CDP-choline on acute pain models in rats: the involvement of cholinergic system. Brain Res (2006) 0.85
Peripheral and central sites of action for A-85380 in the spinal nerve ligation model of neuropathic pain. Pain (2003) 0.85
Multiple spinal mediators in parenteral nicotine-induced antinociception. J Pharmacol Exp Ther (1993) 0.85
ABT-594 (a nicotinic acetylcholine agonist): anti-allodynia in a rat chemotherapy-induced pain model. Eur J Pharmacol (2005) 0.84
The antihyperalgesic effect of cytidine-5'-diphosphate-choline in neuropathic and inflammatory pain models. Behav Pharmacol (2011) 0.83
Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain. Eur J Pharmacol (2011) 0.82
Antinociceptive effects of carbachol microinjected into different portions of the mesencephalic periaqueductal gray matter of the rat. Brain Res (1994) 0.82
Neuronal nicotinic alpha7 receptors modulate early neutrophil infiltration to sites of skin inflammation. J Neuroinflammation (2010) 0.82
Nociceptive thresholds are controlled through spinal β2-subunit-containing nicotinic acetylcholine receptors. Pain (2011) 0.82
Evidence for the tonic inhibition of spinal pain by nicotinic cholinergic transmission through primary afferents. Mol Pain (2007) 0.81
Secondary mechanical allodynia and hyperalgesia depend on descending facilitation mediated by spinal 5-HT₄, 5-HT₆ and 5-HT₇ receptors. Neuroscience (2012) 0.81
Loss of functional neuronal nicotinic receptors in dorsal root ganglion neurons in a rat model of neuropathic pain. Neurosci Lett (2004) 0.81
{alpha}7-nAChR-mediated suppression of hyperexcitability of colonic dorsal root ganglia neurons in experimental colitis. Am J Physiol Gastrointest Liver Physiol (2010) 0.80
Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats. Neurosci Lett (2007) 0.80
Presynaptic nicotinic acetylcholine receptors enhance GABAergic synaptic transmission in rat periaqueductal gray neurons. Eur J Pharmacol (2010) 0.79
Associative tolerance to nicotine analgesia in the rat: tail-flick and hot-plate tests. Exp Clin Psychopharmacol (1998) 0.78
Nicotinic acetylcholine receptors expressed in the ventralposterolateral thalamic nucleus play an important role in anti-allodynic effects. Br J Pharmacol (2010) 0.77
The antinociceptive effect of intrathecal administration of epibatidine with clonidine or neostigmine in the formalin test in rats. Pain (2001) 0.77
Depression by nicotine of pain-related nociceptive activity in the rat thalamus and spinal cord. Clin Investig (1993) 0.76
Antinociceptive and toxic effects of (+)-epibatidine oxalate attributable to nicotinic agonist activity. Br J Pharmacol (1994) 0.76
Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron (2002) 3.78
Cellular and synaptic mechanisms of nicotine addiction. J Neurobiol (2002) 2.68
Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice. Proc Natl Acad Sci U S A (2010) 1.74
Dopamine scales performance in the absence of new learning. Neuron (2006) 1.35
Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. BJU Int (2008) 1.25
Presynaptic opioid and nicotinic receptor modulation of dopamine overflow in the nucleus accumbens. J Neurosci (2008) 1.22
Cholinergic modulation of dopaminergic reward areas: upstream and downstream targets of nicotine addiction. Eur J Pharmacol (2003) 1.14
Stress-induced changes in nucleus accumbens glutamate synaptic plasticity. J Neurophysiol (2009) 1.13
Adenylyl cyclase type 5 contributes to corticostriatal plasticity and striatum-dependent learning. J Neurosci (2009) 1.11
Dopamine neurons in the ventral tegmental area fire faster in adolescent rats than in adults. J Neurophysiol (2012) 1.10
Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons. J Neurophysiol (2007) 1.08
Nicotine potentiation of excitatory inputs to ventral tegmental area dopamine neurons. J Neurosci (2011) 1.04
Short- and long-term enhancement of excitatory transmission in the spinal cord dorsal horn by nicotinic acetylcholine receptors. Proc Natl Acad Sci U S A (2003) 1.04
Short- and long-term modulation of synaptic inputs to brain reward areas by nicotine. Ann N Y Acad Sci (2003) 1.03
Enhanced nicotinic receptor function and drug abuse vulnerability. J Neurosci (2007) 0.97
Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area. Biochem Pharmacol (2007) 0.94
Nicotine and behavioral sensitization. J Mol Neurosci (2009) 0.91
Nicotinic modulation of GABAergic synaptic transmission in the spinal cord dorsal horn. Brain Res (2005) 0.90
A role for dopamine-mediated learning in the pathophysiology and treatment of Parkinson's disease. Cell Rep (2012) 0.88
Nicotinic excitation of serotonergic projections from dorsal raphe to the nucleus accumbens. J Neurophysiol (2011) 0.86
Intermittent nicotine exposure upregulates nAChRs in VTA dopamine neurons and sensitises locomotor responding to the drug. Eur J Neurosci (2013) 0.84
Nicotinic receptors regulate the dynamic range of dopamine release in vivo. J Neurophysiol (2013) 0.81
Long-lived retrograde fluorescent labeling of corticospinal neurons in the living animal. Brain Res Brain Res Protoc (2004) 0.80
Glutamate receptor expression and chronic glutamate toxicity in rat motor cortex. Neurobiol Dis (2007) 0.79
Cyclic AMP and afferent activity govern bidirectional synaptic plasticity in striatopallidal neurons. J Neurosci (2014) 0.78
Tunicamycin produces TDP-43 cytoplasmic inclusions in cultured brain organotypic slices. J Neurol Sci (2012) 0.78
GIRK channels as a target for SSRIs. Focus on "reduced 5-HT1A- and GABAB receptor function in dorsal raphe neurons upon chronic fluoxetine treatment of socially stressed rats". J Neurophysiol (2007) 0.75
Nicotinic Modulation of Descending Pain Control Circuitry. Pain (2017) 0.75